[1]
|
Abraham. J. (2002). The pharmaceutical industry as a political player. Lancet, 360, 1498-1502. doi:10.1016/S0140-6736(02)11477-2
|
[2]
|
Centre for Disease Controls and Prevention in United States (2011), National Vital Statistics Reports. URL (last checked 12 September 2012). http://www.cdc.gov/nchs/data/nvsr/nvsr60/nvsr60_01.pdf
|
[3]
|
Cooke, M., Irby, D. M., Sullivan, W., & Ludmerer, K. M. (2006). American medical education 100 years after the flexner report. New England Journal of Medicine, 355, 1339-1344.
doi:10.1056/NEJMra055445
|
[4]
|
Devereaux, P. J., Schünemann, H. J., Ravindran, N., Bhandari, M., Garg, A., Choi, P. et al. (2002). Comparison of mortality between private for-profit and private not-for-profit hemodi alysis centers: A systematic review and meta-analysis. Journal of American Medical Association, 288, 2449-2457. doi:10.1001/jama.288.19.2449
|
[5]
|
Davidson, L., & Greblov, G. (2005), The Pharmaceutical industry in the global economy. URL (last checked 12 September 2012).
http://www.bus.indiana.edu/davidso/lifesciences/lsresearchpapers/pharmaceutical%20industryaug12.doc
|
[6]
|
Ford, N. (2003). Public health and company wealth, British Medical Journal, 326, 1296.
|
[7]
|
Fortune Magazine. URL (last checked 12 September 2012).
http://money.cnn.com/magazines/fortune/fortune500/index.html
|
[8]
|
Fortune 500 Database. URL (last checked 12 September 2012).
http://money.cnn.com/magazines/fortune/fortune500_archive/letters/P.html
|
[9]
|
Gagnon, M.-A., & Lexchin, J. (2008). The cost of pushing pills: A new estimate of pharmaceutical promotion expenditures in the United States. PLoS Medicine, 5, e1. doi:10.1371/journal.pmed.0050001
|
[10]
|
Garg, P. P., Frick, K. D., Diener-West, M., & Powe, N. R. (1999) Effect of the ownership of dialysis facilities on patients’ survival and referral for transplantation. The New England Journal of Medicine, 341, 1653-1660
|
[11]
|
Geyman, J. P. (2003).Corporate transformation of medicine and its impact on cost and access to care, The Journal of the American Board of Family Medicine, 16, 443-454.
|
[12]
|
Ghosh, S. (2010). Increasing trend in caesarean section delivery in India: Role of medicalisation of maternal health. Bangalore: The Institute for Social and Economic Change,.
http://www.isec.ac.in/WP%20236%20-%20Sancheeta%20Ghosh.pdf
|
[13]
|
Gray, B. H. (1986) For-profit enterprise in health care. Washington DC: National Academy Press.
|
[14]
|
Hopkins, K., & Amaral, E. (2005). The role of nonclinical factors in cesarean section rates in Brazil. URL (last checked 12 September 2012).
http://paa2005.princeton.edu/download.aspx?submissionId=50741
|
[15]
|
Johnston, S., Moss, K., Brown, A. (2011) The business of virtualization in research and development. URL (last checked 12 September 2012).
http://www.oracle.com/us/industries/health-sciences/virtualization-pharma-br-1638314.pdf
|
[16]
|
Kefauver, E. (1965) In a few hands. Harmondsworth: Penguin.
|
[17]
|
Lee, M. (2011) Designer vagina surgery: snip, stitch, kerching! URL (last checked 12 September 2012).
http://www.guardian.co.uk/lifeandstyle/2011/oct/14/designer-vagina-surgery
|
[18]
|
Moynihan, R., Heath, I., & Henry, D. (2002). Selling sickness: The pharmaceutical industry and disease mongering. British Medical Journal, 324, 886-891.
|
[19]
|
NIHCM (2002). Changing patterns of pharmaceutical innovation. URL (last checked 12 September 2012).
http://www.nihcm.org/pdf/innovations.pdf
|
[20]
|
Public Citizen (2003). 2002 drug industry profits: Hefty Pharmaceutical Company margins dwarf other industries. URL (last checked 12 September 2012).
http://www.citizen.org/documents/Pharma_Report.pdf
|
[21]
|
Puliyel, J. M., & Madhavi, Y. (2008). Editorial. Indian Journal of Medical Research, 127, 1-3
|
[22]
|
Relman, A. S. (1980). The new medical-industrial complex. New England Journal of Medicine, 303, 963-970.
doi:10.1056/NEJM198010233031703
|
[23]
|
Relman, A. S. (1997). Market for healthcare: Where is the patient? Clinical Chemistry, 43, 2225-2229.
|
[24]
|
Starr, P. (1082). The social transformation of American medicine. New York: Basic Books
|
[25]
|
Thamer, M., Zhang, Y., Kaufman, J., Cotter, D., Dong, F., & Hernán, M. A. (2007). Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis. The Journal of the American Medical Association, 15, 1667-1674. doi:10.1001/jama.297.15.1667
|
[26]
|
Treatment action Group (2007). URL (last checked 12 September 2012).
http://www.treatmentactiongroup.org/tagline/2007/september/worldwide-antiretroviral-drug-sales-2006
|
[27]
|
Trouiller, P., Olliaro, P., Torreele, E., Orbinski, J., Laing, R., & Ford, N. (2002). Drug development for neglected diseases: A deficient market and a public-health policy failure. The Lancet, 359, 2188-2194.
doi:10.1016/S0140-6736(02)09096-7
|
[28]
|
United States Renal Data System (2206). Excerpts from the USRDS 2006 annual data report. American Journal of Kidney Diseases, 49, S1-S296.
|
[29]
|
Weintraub, P. (2010). The Dr. who drank infectious broth, gave himself an ulcer, and solved a medical mystery. Discover Magazine.
http://discovermagazine.com/2010/mar/07-dr-drank-broth-gave-ulcer-solved-medical-mystery
|
[30]
|
WHO (2012) List of neglected tropical disease. URL (last checked 12 September 2012).
http://www.who.int/neglected_diseases/diseases/en/
|